1. Shields MB. Gray crescent in the optic nerve head. Am J Ophthalmol. 1980; 89:238–44.
Article
2. Higginbotham L, Shafranov G, Shields MB. Gray optic disc crescent influence of ethnicith in a glaucoma population. J Glaucoma. 2007; 16:572–6.
3. Jonsson O, Damji KF, Jonasson F, et al. Epidemiology of the optic nerve gray crescent in the Reykjavik Eye Study. Br J Ophthalmol. 2005; 89:36–9.
4. Fournier AV, Damji KF, Epstein DL, Pollock SC. Disc excavation in dominant optic atrophy: differentiation from normal tension glaucoma. Ophthalmology. 2001; 108:1595–602.
5. Araie M, Sekine M, Suzuki Y, Koseki N. Factors contributing to the progression of visual field damage in eyes with normal-tension glaucoma. Ophthalmology. 1994; 101:1440–4.
Article
6. Jonas JB, Nguyen XN, Gusek GC, Naumann GO. Parapapillary chorioretinal atrophy in normal and glaucoma eyes. I. Morphometric data. Invest Ophthalmol Vis Sci. 1989; 30:908–18.
7. Jonas JB, Naumann GO. Parapapillary chorioretinal atrophy in normal and glaucoma eyes. II. Correlations. Invest Ophthalmol Vis Sci. 1989; 30:1604–11.
8. Park KH, Tomita G, Liou SY, Kitazawa Y. Correlation between peripapillary atrophy and optic nerve damage in normal-tension glaucoma. Ophthalmology. 1996; 103:1899–906.
Article
9. Jonas JB. Clinical implications of peripapillary atrophy in glaucoma. Curr Opin Ophthalmol. 2005; 16:84–8.
Article
10. Teng CC, De Moraes CG, Prata TS, et al. The region of largest β-zone parapapillary atrophy area predicts the location of most rapid visual field progression. Ophthalmology. 2011; 118:2409–13.
Article